[The importance to forewarn or to recommend the indications for renal dialysis].
Navazio
F
F
Department of Integrative Biology, 5101 VLSB, University of California at Berkeley, CA 94720-3140, USA.
D000419:Albuminuria / Q000150:complications / Q000628:therapy; D000740:Anemia / Q000150:complications / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D008954:Models, Biological; D010530:Peritoneal Dialysis; D011507:Proteinuria / Q000150:complications; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy*; D012307:Risk Factors; D012737:Sex Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004921:Erythropoietin; D003404:Creatinine